Department: Cell Research and Immunology
Faculty: Life Sciences
Tel Aviv University

Prof. LEDERKREMER Gerardo Zelmar


Prof. Lederkremer’s lab has been interested in the mechanisms of protein folding and trafficking in the early secretory pathway of mammalian cells. He has focused especially on mechanisms of ER protein quality control and on recognition and delivery of misfolded proteins from the ER to the cytosolic proteasomes for ERAD. These processes are intimately linked to the genesis of ER stress, which he has also been studying.  Specific research topics are:

  • Protein misfolding diseases, including neurodegenerative diseases.
  • ER stress.
  • Mechanisms of endoplasmic reticulum (ER) protein folding and quality control.
  • Sugar chain trimming processes as cellular signals for glycoprotein folding status.
  • Delivery of misfolded proteins to ER-associated degradation (ERAD).
  • Subcellular compartmentalization of ER quality control and ERAD.

His research in these areas has led to some important discoveries. One of them is the identification of a novel subcellular compartment involved in these processes, as a staging ground for ERAD. The second is a process that modifies specifically the sugar chains of misfolded glycoproteins after refolding attempts have failed, creating a signal for delivery to ERAD. He also found that components of the cellular machinery that deliver these misfolded glycoproteins to ERAD have a dual specificity, also for non-glycosylated proteins. These processes are regulated by ER stress and the consequent unfolded protein response (UPR) and he has established that the compartmentalization and assembly of a molecular complex that targets to ERAD are dependent on one of the branches of the UPR. His group has recently found that interference with ERAD and upregulation of the UPR are a main mechanism of cell damage in a neurodegenerative disorder, Huntington’s disease, and that this occurs prior to the appearance of the characteristic large protein inclusions that occur in this disease.

Sign up for
our events

    Life Science